Posted in | News | Nanomaterials | Nanobusiness

Carbon Nanotubes from Bayer to Be Used in Hyperion Patents

Hyperion Catalysis International, Inc. (Hyperion) has concluded a patent license agreement with Bayer MaterialSciences AG (BMS), a Bayer Group company. In exchange for certain payments, the agreement provides that BMS will be able to sell its Baytubes carbon nanotubes for use within a defined field under Hyperion's extensive patent portfolio.

The license agreement will help BMS to continue to grow its position as one of the world's leading carbon nanotube suppliers by providing its customers access to additional applications for BMS's carbon nanotube based products.

David M. Wohlstadter, Hyperion's Vice President of Business Development stated, "We are quite pleased to have entered into this arrangement with BMS. This license with BMS will further leverage Hyperion's broad patent portfolio and capitalize on the ever increasing demand for carbon nanotubes. We feel BMS is well poised to serve and help increase this demand, while Hyperion remains committed to expanding its own sales and providing its customers with the highest quality carbon nanotube based products."

Hyperion's flagship FIBRIL technology is a conductive, multi-walled carbon nanotube, which is based on the pioneering work in the field by Dr. Howard G. Tennent. Hyperion, which is headquartered in Cambridge, Massachusetts, USA, has been manufacturing and selling its FIBRILTM carbon nanotubes for a wide range of applications since 1983.

Hyperion has devoted substantial resources to developing, improving and patenting the technology related to the manufacture and use of carbon nanotubes. Hyperion currently has hundreds of issued patents and patent applications covering the production and use of carbon nanotubes. Hyperion supplies its FIBRIL nanotubes, pre-mixed, in a range of matrices. These nanotube composites are in commercial use in a number of fields including automotive and electronics. The FIBRIL nanotubes are used to impart electrical conductivity and other benefits that are related to the unique structure of the nanotubes.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Covestro AG. (2019, February 12). Carbon Nanotubes from Bayer to Be Used in Hyperion Patents. AZoNano. Retrieved on July 13, 2024 from

  • MLA

    Covestro AG. "Carbon Nanotubes from Bayer to Be Used in Hyperion Patents". AZoNano. 13 July 2024. <>.

  • Chicago

    Covestro AG. "Carbon Nanotubes from Bayer to Be Used in Hyperion Patents". AZoNano. (accessed July 13, 2024).

  • Harvard

    Covestro AG. 2019. Carbon Nanotubes from Bayer to Be Used in Hyperion Patents. AZoNano, viewed 13 July 2024,

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.